Premium Alternative Insight and Premium Journalism
The life sciences hedge fund has targeted a biopharmaceuticals company that specializes in HIV medicines.
The Latest
The legendary macro investor fully unloaded nearly half his portfolio in the third quarter.
Lone Pine, Viking, D1, Tiger Global, and Maverick made significant changes to their portfolios.
TCI’s liquidation of Microsoft was just one of a number of notable disclosures in the latest round of 13F filings.
October was an especially rough month for the sickly sector.
The world’s largest hedge fund firm is betting on sustainability and Asia.
Why the hedge fund firm expects the economy to be rocked by geopolitics, and how it is positioned.
Sponsored
